☆ 3.8 Article

Serum bilirubin levels are negatively associated with atherogenic lipids in Saudi subjects with type 2 diabetes: A pilot study

ELECTRONIC JOURNAL OF GENERAL MEDICINE (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Hong Sun et al.

Summary: This study provides global, regional, and country-level estimates of diabetes prevalence and health expenditures for 2021 and projections for 2045. The global prevalence of diabetes is increasing and is expected to have the greatest relative increase in middle-income countries. Diabetes-related health expenditures are also projected to rise.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Bilirubin as an indicator of cardiometabolic health: a cross-sectional analysis in the UK Biobank

Nazlisadat Seyed Khoei et al.

Summary: There is an inverse association between bilirubin levels and cardiometabolic risk factors including adiposity, dyslipidemia, and hypertension.

CARDIOVASCULAR DIABETOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Small Dense LDL: Scientific Background, Clinical Relevance, and Recent Evidence Still a Risk Even with 'Normal' LDL-C Levels

Harold Superko et al.

Summary: Despite statin use and LDL-C reduction, residual cardiovascular disease event risk remains. Abnormal lipoprotein size and density distribution, known as lipoprotein heterogeneity, contributes to this residual risk. Recent clinical trial evidence reinforces the importance of LDL heterogeneity measurement and its impact on CHD risk prediction and outcomes.

BIOMEDICINES (2022)

添加到收藏夹

Review Endocrinology & Metabolism

Bilirubin as a metabolic hormone: the physiological relevance of low levels

Justin F. Creeden et al.

Summary: Recent research indicates that bilirubin may have a new role as a metabolic hormone, potentially leading to cardiovascular complications for patients with low levels. Protective mechanisms at mildly elevated levels of bilirubin could offer treatment possibilities for those with hypobilirubinemia.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2021)

添加到收藏夹

Article Endocrinology & Metabolism

Associations between serum total bilirubin, obesity and type 2 diabetes

Yuan Wei et al.

Summary: The study found that individuals with lower serum total bilirubin levels had a significantly higher risk of type 2 diabetes compared to those with moderate or high levels. Additionally, it was discovered that body mass index (BMI) may moderate the association between bilirubin and type 2 diabetes, with a stronger effect observed in obese individuals. This study suggests that serum total bilirubin is associated with an increased risk of type 2 diabetes and that this association may be influenced by obesity.

DIABETOLOGY & METABOLIC SYNDROME (2021)

添加到收藏夹

Article Medical Laboratory Technology

A New Equation Based on the Standard Lipid Panel for Calculating Small Dense Low-Density Lipoprotein-Cholesterol and Its Use as a Risk-Enhancer Test

Maureen Sampson et al.

Summary: The study introduces two new equations for calculating large buoyant LDL-C and small dense LDL-C based on standard lipid panel results. The equations were found to potentially improve ASCVD risk stratification.

CLINICAL CHEMISTRY (2021)

添加到收藏夹

Review Biochemistry & Molecular Biology

Bilirubin as a Therapeutic Molecule: Challenges and Opportunities

Christopher A. Adin

Summary: Serum free bilirubin concentration has significant effects on morbidity and mortality in major health conditions such as cardiovascular disease, diabetes, and obesity/metabolic syndrome. Challenges in using bilirubin as a therapeutic agent in human patients include poor solubility, complex molecular structure, and concerns about animal-derived sources. However, advancements in drug delivery, biosynthetic strategies, and drug synthesis offer new possibilities for applying bilirubin as a pharmaceutical agent.

ANTIOXIDANTS (2021)

添加到收藏夹

Review Medical Laboratory Technology

Small dense low-density lipoprotein: Analytical review

Christina Kanonidou

Summary: Various methods exist for the analysis of LDL subfractions and the measurement of sdLDL particle characteristics, with ultracentrifugation, gradient gel electrophoresis, NMR spectroscopy, and homogeneous assay being common. While there is no gold standard, ultracentrifugation and GGE are established techniques, while NMR and homogeneous assay are rapid and high-throughput options. However, none of the proposed equations for calculated sdLDL determination have been sufficiently validated for clinical use.

CLINICA CHIMICA ACTA (2021)

添加到收藏夹

Article Endocrinology & Metabolism

An Update on the Epidemiology of Type 2 Diabetes: A Global Perspective

Maria G. Tinajero et al.

ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2021)

添加到收藏夹

Article Biochemistry & Molecular Biology

Oxidative Stress and Related Biomarkers in Gilbert's Syndrome: A Secondary Analysis of Two Case-Control Studies

Karl-Heinz Wagner et al.

Summary: Subjects with Gilbert's syndrome show higher levels of antioxidant potential and protein oxidation products, as well as lower levels of apolipoprotein B, hs-C-reactive protein, interleukin 6, and interleukin 1 beta compared to healthy controls. Resting heart rate is also significantly lower in the GS group. Older subjects with GS demonstrate stronger protective effects.

ANTIOXIDANTS (2021)

添加到收藏夹

Review Medical Laboratory Technology

Diabetic dyslipidaemia

Subashini C. Thambiah et al.

Summary: Diabetic dyslipidaemia plays a crucial role in the interaction between diabetes and atherosclerotic cardiovascular disease, involving both quantitative and qualitative abnormalities in lipoproteins, with established pathophysiology. Recognizing and managing diabetic dyslipidaemia can reduce cardiovascular risk in patients.

PRACTICAL LABORATORY MEDICINE (2021)

添加到收藏夹

Article Medical Laboratory Technology

Correlations between Direct and Calculated Low-Density Lipoprotein Cholesterol Measurements in Children and Adolescents

Sultan Alouffi et al.

JOURNAL OF CLINICAL LABORATORY ANALYSIS (2020)

添加到收藏夹

Review Pharmacology & Pharmacy

Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting

Josefin Soppert et al.

ADVANCED DRUG DELIVERY REVIEWS (2020)

添加到收藏夹

Review Peripheral Vascular Disease

Bilirubin and Endothelial Function

Tatsuya Maruhashi et al.

JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2019)

添加到收藏夹

Article Oncology

Total bilirubin is negatively related to diabetes mellitus in Chinese elderly: a community study

Ping Zhong et al.

ANNALS OF TRANSLATIONAL MEDICINE (2019)

添加到收藏夹

Review Cardiac & Cardiovascular Systems

The Atherogenic Dyslipidemia Complex and Novel Approaches to Cardiovascular Disease Prevention in Diabetes

Priska Stahel et al.

CANADIAN JOURNAL OF CARDIOLOGY (2018)

添加到收藏夹

Review Cell Biology

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases

Ekaterina A. Ivanova et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2017)

添加到收藏夹

Article Multidisciplinary Sciences

Bilirubin Binding to PPARα Inhibits Lipid Accumulation

David E. Stec et al.

PLOS ONE (2016)

添加到收藏夹

Article Hematology

Circulating Total Bilirubin and Risk of Incident Cardiovascular Disease in the General Population

Setor K. Kunutsor et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)

添加到收藏夹

Review Endocrinology & Metabolism

Pathophysiology of diabetic dyslipidaemia: where are we?

Bruno Verges

DIABETOLOGIA (2015)

添加到收藏夹

Article Biochemistry & Molecular Biology

Bilirubin scavenges chloramines and inhibits myeloperoxidase-induced protein/lipid oxidation in physiologically relevant hyperbilirubinemic serum

A. C. Boon et al.

FREE RADICAL BIOLOGY AND MEDICINE (2015)

添加到收藏夹

Article Medical Laboratory Technology

Increased large VLDL and small LDL particles are related to lower bilirubin in Type 2 diabetes mellitus

Robin P. F. Dullaart et al.

CLINICAL BIOCHEMISTRY (2014)

添加到收藏夹

Review Nutrition & Dietetics

Lipoprotein Subfractions in Metabolic Syndrome and Obesity: Clinical Significance and Therapeutic Approaches

Dragana Nikolic et al.

NUTRIENTS (2013)

添加到收藏夹

Editorial Material Medicine, General & Internal

Everyone under statin?

Helene Vaillant-Roussel et al.

EXERCER-LA REVUE FRANCOPHONE DE MEDECINE GENERALE (2012)

添加到收藏夹

Review Pharmacology & Pharmacy

The role of bilubinin diabetes, metabolic syndrome, and cardiovascular diseases

Libor Vitek

FRONTIERS IN PHARMACOLOGY (2012)

添加到收藏夹

Article Medicine, General & Internal

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

B. Mihaylova et al.

LANCET (2012)

添加到收藏夹

Article Endocrinology & Metabolism

Biliverdin protects against the deterioration of glucose tolerance in db/db mice

N. Ikeda et al.

DIABETOLOGIA (2011)

添加到收藏夹

Article Medicine, General & Internal

Serum total bilirubin level, prevalent stroke, and stroke outcomes: NHANES 1999-2004

Todd S. Perlstein et al.

AMERICAN JOURNAL OF MEDICINE (2008)

添加到收藏夹

Review Biochemistry & Molecular Biology

Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL

Anton F. H. Stalenhoef et al.

CURRENT OPINION IN LIPIDOLOGY (2008)

添加到收藏夹

Article Medicine, Research & Experimental

Inverse relationship between serum bilirubin and atherosclerosis in men:: A meta-analysis of published studies

L Novotny et al.

EXPERIMENTAL BIOLOGY AND MEDICINE (2003)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

SM Grundy et al.

CIRCULATION (2002)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.